Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.81 |
| ▸ | TSHR | P16473 | 4/20 | 0.81 |
| ▸ | LMNA | P02545 | 2/20 | 0.81 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.70 |
| ▸ | KDM4A | O75164 | 1/20 | 0.56 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8927603 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1923016 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL1005991 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| 2-Hydroxybenzoic Acid Hexyl Ester SCHEMBL113059 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL4731100 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL8927962 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL167484 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL7459965 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL411474 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 | |
| SCHEMBL2798676 | 1.00 | ALDH1A1 (0.81) | ALDH1A1TSHRLMNACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111303551-B | Vinyl chloride resin compound and preparation method thereof | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2021-06-22 | — | — | CN | claimed |
| CN-109134765-B | Graft copolymer of polyisobutylene and polyisoprene and preparation method thereof | 北京化工大学 | 2020-11-03 | — | — | CN | claimed |
| CN-111303551-A | Vinyl chloride resin compound and preparation method thereof | 北京化工大学 | 2020-06-19 | — | — | CN | claimed |
| CN-110016170-A | A kind of low water vapor transmittance polyolefin elastomer glue film and preparation method | 杭州福斯特应用材料股份有限公司 | 2019-07-16 | — | — | CN | claimed |
| CN-103341701-B | Flux for soft soldering | SHENMAO ELECTRONIC TECHNOLOGY (CHONGQING) Co.,Ltd. (CN) | 2015-08-19 | — | — | CN | claimed |
| US-9006327-B2 | Process for preparing precomposites based on nanotubes, particularly carbon nanotubes | ARKEMA FRANCE (FR) | 2015-04-14 | — | — | US | claimed |
| CN-103341701-A | Flux for soft soldering | SHENMAO ELECTRONIC TECHNOLOGY CHONGQING CO LTD | 2013-10-09 | — | — | CN | claimed |
| CN-101407642-B | Production method of pre-composite based on nanotube, especially carbon nanotube | ARKEMA FRANCE | 2012-12-19 | — | — | CN | claimed |
| CN-101407642-A | Production method of pre-composite based on nanotube, especially carbon nanotube | ARKEMA FRANCE (FR) | 2009-04-15 | — | — | CN | claimed |
| US-20080312364-A1 | PROCESS FOR PREPARING PRECOMPOSITES BASED ON NANOTUBES, PARTICULARLY CARBON NANOTUBES | ARKEMA FRANCE (FR) | 2008-12-18 | — | — | US | claimed |
| EP-0987011-B1 | Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use | OREAL (FR) | 2002-07-17 | — | — | EP | claimed |
| US-6281203-B1 | ESTER OF A FATTY ACID AND GLUCOSE AND/OR ALKYLGLUCOSE, AND AN OXYETHYLENATED ETHER OF A FATTY ACID ESTER OF GLUCOSE AND/OR ALKYLGLUCOSE. | L'OREAL (FR) | 2001-08-28 | — | — | US | claimed |
| US-5559098-A | Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic | ROEHM PHARMA GMBH (DE) | 1996-09-24 | — | — | US | claimed |
| CN-122095024-A | Flame-retardant aromatic polycarbonate resin composition and molded article thereof | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026100296-A1 | FLAME-RETARDANT AROMATIC POLYCARBONATE RESIN MASTER BATCH AND METHOD FOR MANUFACTURING SAME | 信越化学工業株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260008920-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | TEIJIN LIMITED (JP) | 2026-01-08 | — | — | US | disclosed |
| US-5476843-A | Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic | ROEHM PHARMA GMBH (DE) | 1995-12-19 | — | — | US | disclosed |
| EP-0524475-B1 | Viscosity index improver | SANYO CHEMICAL IND LTD (JP) | 1995-04-26 | — | — | EP | disclosed |
| US-5344863-A | Polyolefin, dispersant and phenolic derivative | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-06 | — | — | US | disclosed |
| EP-0524475-A1 | Viscosity index improver | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1993-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008920-A1 | POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF | NOP2, CCT2, RPL8 | ALDH1A1 1820/4885TSHR 3886/4885LMNA 1641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.